A detailed history of Goldman Sachs Group Inc transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 115,140 shares of TOI stock, worth $347,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,140
Previous 115,140 -0.0%
Holding current value
$347,722
Previous $131,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$0.29 - $1.26 $33,390 - $145,076
115,140 New
115,140 $131,000
Q2 2022

Aug 15, 2022

SELL
$4.78 - $9.89 $47,957 - $99,226
-10,033 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.97 - $9.85 $421,078 - $1.04 Million
-106,065 Reduced 91.36%
10,033 $72,000
Q4 2021

Feb 14, 2022

BUY
$6.15 - $10.98 $714,002 - $1.27 Million
116,098 New
116,098 $1.13 Million

Others Institutions Holding TOI

About Oncology Institute, Inc.


  • Ticker TOI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 73,495,504
  • Market Cap $222M
  • Description
  • The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...
More about TOI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.